4//SEC Filing
Cashmere Karen A. 4
Accession 0001493152-22-035481
CIK 0001859007other
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 7:27 PM ET
Size
14.5 KB
Accession
0001493152-22-035481
Insider Transaction Report
Form 4
Cashmere Karen A.
Chief Commercial Officer
Transactions
- Award
Stock Options (right to buy)
2022-12-12+19,854→ 19,854 totalExercise: $5.03Exp: 2027-10-30→ Common Stock (19,854 underlying) - Award
Stock Options (right to buy)
2022-12-12+9,927→ 9,927 totalExercise: $5.03Exp: 2024-09-10→ Common Stock (9,927 underlying) - Award
Stock Options (right to buy)
2022-12-12+29,781→ 29,781 totalExercise: $11.58Exp: 2029-04-02→ Common Stock (29,781 underlying) - Award
Stock Options (right to buy)
2022-12-12+21,840→ 21,840 totalExercise: $16.36Exp: 2031-02-08→ Common Stock (21,840 underlying) - Award
Stock Options (right to buy)
2022-12-12+21,840→ 21,840 totalExercise: $16.36Exp: 2032-01-28→ Common Stock (21,840 underlying)
Footnotes (5)
- [F1]100% of the option is immediately exercisable. The option vested in 3 equal annual installments commencing on September 10, 2014.
- [F2]100% of the option is immediately exercisable. The option vested in 4 equal annual installments commencing on October 30, 2017.
- [F3]100% of the option is immediately exercisable. The option vested in 3 equal annual installments commencing on April 2, 2020.
- [F4]The option vests in 3 equal annual installments commencing on February 8, 2022.
- [F5]The option vests in 3 equal annual installments commencing on January 28, 2023.
Documents
Issuer
ZyVersa Therapeutics, Inc.
CIK 0001859007
Entity typeother
Related Parties
1- filerCIK 0001954546
Filing Metadata
- Form type
- 4
- Filed
- Dec 13, 7:00 PM ET
- Accepted
- Dec 14, 7:27 PM ET
- Size
- 14.5 KB